Would you consider atezolizumab-bevacizumab combination in a patient with metastatic hepatocellular carcinoma who presented with paraneoplastic myasthenia gravis?  

Paraneoplastic myasthenia gravis from HCC is extremely rare with only a few handful of cases have ever been reported (Choi et al. AJG 2018; Fussner et al. Neurology 2019; Vautravers et al., PMID 19046712). The mechanism of pathogenesis is not known although it is thought to be related to the cross r...